BJH - volume 11, issue 7, november 2020
Y. Serroukh MD, PhD
The present report summarises some of the data shared during the last European Bone Marrow Transplant (EBMT) meeting that was held virtually from the 29th of August to the 1st of September 2020. It is certainly not exhaustive but reflects the author’s selection of relevant data for clinical practice as well as future developments in the field. Cellular therapy against multiple myeloma and non-Hodgkin’s lymphoma were extensively covered in other recent congresses and were not included in this report.
(BELG J HEMATOL 2020;11(7):335-8)Read more
BJH - volume 11, issue 4, june 2020
B. Depreter PhD, PharmD, N. Cools PhD, V.H.J. van der Velden PhD
In November 2019, the Belgian Society for the Advancement of Cytometry (BSAC) and the Dutch Society for Cytometry (NVC) jointly organised a two-day international congress on developments in (flow) cytometry. With over 150 participants, the congress was well attended and received. Here we briefly discuss the most important highlights from this congress.
(BELG J HEMATOL 2020;11(4):185–9)Read more
BJH - volume 11, issue 3, may 2020
J. Blokken PhD, PharmD, T. Feys MBA, MSc
On the 14th and 15th of February 2020, the Belgian Hematology Society hosted their 35th annual meeting in La Hulpe, Brussels. This year’s meeting featured scientific parallel sessions organised by the Belgian Society for Advancement of Cytometry (BSAC), the Belgian Society of Thrombosis and Haemostasis (BSTH), MolecularDiagnostics.be (MD.be) as well as a nurse symposium. In this article, we will highlight the scientific sessions presented during the BHS meeting.
(BELG J HEMATOL 2020;11(3):136–41)Read more
BJH - volume 9, issue 5, september 2018
T. Feys MBA, MSc
From the 20th till the 24th of May 2018, Glasgow formed the background for the annual meeting of the World Federation of Hemophilia (WFH), the largest international meeting for the bleeding disorders community. The therapeutic options for people with haemophilia (PWH) have rapidly evolved in the last five years. Moving on from conventional plasma-derived and recombinant clotting concentrates (CFC), there are now extended half-life CFCs as well as several novel haemostasis agents (e.g. emicizumab). In addition, gene transfer proved to be successful for both haemophilia A and B patients. It has been demonstrated that all these products provide better haemostasis and convenience than conventional CFCs. This summary will focus on new data presented with some of these novel therapeutic options during WFH 2018. For a complete overview of abstracts presented during the meeting we would like to refer to the official congress website (https://www.wfh.org/congress/en/home).
(BELG J HEMATOL 2017;9(5):199–201)Read more
BJH - volume 9, issue 5, september 2018
C. Bonnet MD, PhD, E. Van den Neste MD, PhD, M. André MD, M. Maerevoet MD, M.C. Ngirabacu , V. De Wilde MD, PhD
The 4th edition of the LYSA meeting was organised by Professor Steven Legouill’s team and held in Nantes from the 8th to 10th February, 2018. It was a real opportunity for the 500 participants to learn novelties on lymphoma and to be updated on ongoing clinical trials conducted by this cooperative group. All the presentations were outstanding and gave us new indications on how to better treat our patients in the near future.
(BELG J HEMATOL 2017;9(5):195–8)Read more
BJH - volume 4, issue 3, september 2013
A. Ferster MD, PhD, B. Gulbis MD, PhD
During the twelfth meeting dedicated to sickle cell disease and hereditary red cell disorders held in Brussels on 21 February 2013, several topics related to major aspects for the management of sickle cell disease were presented. Six of them are summarised.
(BELG J HEMATOL 2013;4(3): 115–116)Read more
BJH - volume 4, issue 2, june 2013
A. Gothot MD, PhD, A. Kornreich MD
For the first time, during the course of its general annual meeting, the BHS hosted a satellite meeting organized by the Belgian Society for Analytical Cytology (BVAC/ABCA) to bring together clinicians with laboratory scientists and staff. The BVAC/ABCA program included state-of-the-art lectures, followed by a session focused on advances in genetic testing of haematological malignancies and finally a satellite symposium sponsored by Alexion on the deficiencies of complement regulators leading to thrombotic micro-angiopathies (TMA). All these presentations are available on the BVAC/ABCA website: http://www.cytometry.be/Gent2013.html
(BELG J HEMATOL 2013;4(2):77–82)Read more